News Daily News Risk Factors Present in Nearly All Patients Who Develop CVD Michael O'Riordan October 02, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Conference News AHA 2024 ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS Michael O'Riordan November 21, 2024
News Conference News AHA 2024 Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III Caitlin E. Cox November 21, 2024
News Daily News Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE Yael L. Maxwell August 19, 2024
News Daily News Dramatic LDL Drops Seen in PAD Patients With Team-Based Care L.A. McKeown June 18, 2024
News Conference News ACC 2024 Need a Statin for Primary Prevention? There’s an App for That Michael O'Riordan April 10, 2024
News Daily News High Lp(a) Levels Harmful in Patients With and Without ASCVD Michael O'Riordan February 27, 2024
News Conference News AHA 2023 Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH Caitlin E. Cox November 12, 2023
News Daily News Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow Michael O'Riordan November 02, 2023
News Daily News Small Study Hints at Mechanism for COVID-Related MI and Stroke L.A. McKeown October 02, 2023
News Daily News Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE Michael O'Riordan July 25, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News USPSTF: Screening Kids for Lipid Disorders Still Needs More Data Shelley Wood July 18, 2023
News Conference News ADA 2023 Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention Michael O'Riordan June 28, 2023
News Conference News EAS 2023 Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH Michael O'Riordan May 24, 2023
News Daily News Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term L.A. McKeown March 31, 2023
News Conference News ACC 2023 Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin Yael L. Maxwell March 13, 2023
News Conference News ACC 2023 Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study Todd Neale March 10, 2023
News Daily News Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC Michael O'Riordan March 01, 2023